No video
  • WMUK
  • Жыл бұрын
  • 279
  • 1

zanubrutinib Q & A with Jane Nicholson, CEO

A Q and A session with Jane Nicholson, CEO of WMUK following
decisions from NICE and SMC regarding the approval of the BTK Inhibitor zanubrutinib

Пікірлер: 1

  • @clairelouisecrocker
    @clairelouisecrocker Жыл бұрын

    Thanks Jane and Bob

Келесі